Program

Wednesday, September 4:

10.00-            Registration

12.50-13.00   Welcome, Local organizing committee

GENOMICS

13.00-13.35   Stefan Niemann, Research Center Borstel, Germany: Evolution and transmission of drug-resistant M. tuberculosis strains

13.40-14.15   Kirsten Bos, Max Planck Institute, Leipzig, Germany: M. pinnipedii in the pre-columbus era in Peru

14.20-14.40  Or01, Charlotte Genestet, Centre International de Recherche en Infectiologie (CIRI), France: Translational approach to decipher M. tuberculosis adaptation to new individuals

14.40-14.55  Or02, Clara Braian, Linköping University, Sweden: Genetic and epigenetic characterization of M. abscessus isolates of different colony morphology and their fate during macrophage infection.

15.00-15.30   COFFEE

CELL BIOLOGY & METABOLISM

15.30-16.05   Caroline Barisch, Center for Structural Systems Biology, Germany: Host-microbe interactome of M. marinum in model organisms

16.10-16.45    Amit Singhal, A*STAR Infectious Diseases Labs, Singapore: Metabolism and TB

16.50-17.05   Or03 Tiago Beites, University of Porto, Portugal: Disrupting M. tuberculosis adaptation to host free fatty acids

17.05-17.20   Or04 Nuno Rufino De Sousa, Karolinska Institutet, Sweden: M. tuberculosis survival and replication is impaired after short-term aerosolization

KEYNOTE TALK

17.20-18.00    Katrin Mayer Barber, Laboratory of Clinical Immunology & Microbiology, NIH, USA: Mechanistic insights in TB disease

19:00-            MINGLE BUFFET and POSTER SESSION

 

Thursday, September 5:

HOST IMMUNE RESPONSE

08:30-09.05   Anca Dorhoi, Friedrich-Loeffler Institute, Germany: Immunoregulation in TB

09.10-09.45   Olivier Neyrolles, IPBS-Toulouse, France: Unveiling Lung Innervation in TB Granulomas and Beyond

09.50-10.05   Or05 Tobias Dallenga, Research Center Borstel, Germany: M. tuberculosis reroutes NETosis away from PAD4 towards Gasdermin D and its prevention results in bacterial control

10.05-10.35   COFFEE

10.35-11.10   Al Leslie, Africa Health Research Institute, Durban, South Africa: T cell immunity in the TB granuloma

11.15-11.50   Christine Stabell Benn, University of Southern Denmark, Denmark: BCG vaccine-induced specific and non-specific effects

11.50-12.10  Or06, Bavesh Kana, University of the Witwatersrand, South Africa: A next-generation BCG candidate engineered to trigger heightened NOD-1 activation offers superior protection against TB in mice

12.10-13.30    LUNCH at Stallmästaregården

 

DIAGNOSIS AND VACCINES

13.30-14.05   Annemieke Geluk, Leiden University, the Netherlands: Immunodiagnostics of mycobacterial diseases

14.10-14.45   Mahdad Noursadeghi, University College, London, UK: Biomarkers in diagnosis of TB

14.50-15.05   Or07, Noelia Alonso Rodriguez, Oslo University Hospital, Norway: Evaluation of T cell immunity in TB as potential biomarker in an anti-inflammatory personalized medicine strategy

15.05-15.35  COFFEE

15.35-16.10    Iman Satti, The Jenner Institute, University of Oxford, UK: Mucosal vaccines in TB

16.15-16.50   Thomas Lindenstrøm, Statens Serum Institut, Denmark: T cell immunity with relevance for TB vaccine development

16.50-17.05   Or08, Christopher Sundling, Karolinska Institutet, Sweden: Evaluation of novel tests for early diagnosis of tuberculosis (ERASE-TB)

19.00-            CONFERENCE DINNER

 

Friday, September 6:

CLINICAL MANAGEMENT

08.30-09.05   Jakko van Ingen, Radboud University Nijmegen Medical Center, the Netherlands: Management of non-tuberculous mycobacteria

09.10-09.25   Or09, Reto Guler, University of Cape Town, South Africa: Immunomodulatory activities of atorvastatin on PBMCs from successfully treated TB patients presenting with or without persisting lung inflammation – preliminary findings of StatinTB trial

09.30-09.45  Or10, Sanne van der Niet, Electron Microscopy Centre Amsterdam (EMCA), the Netherlands: From electron microscope to a potential new treatment for mycobacterial infections

09.45-10.00  Or11, Alexandre Gouzy, Weill Cornell Medicine, NY, USA: Shedding light on pyrazinamide’s mode of action and resistance

10.05-10.35    COFFEE

10.35-11.10   Robert Wilkinson, University of Cape Town, South Africa/Crick Institute, UK: Recent advances in TB treatment

11.15-11.50   Francisco Roca, University of Murcia, Spain: Host-directed therapies for TB

11.55-12.10   Maria Lerm, Linköping University, and Susanna Brighenti, Karolinska Institutet, Sweden: Epigenetics in M. tuberculosis infection with new approaches for host-directed therapies and treatment monitoring

12.10-12.15    Closure (organizing committee)

 

>>Program above as pdf (updated Aug-28)